Authors: Edelbroek, PM Augustijn, PB De Haan, GJ Rademaker, MV Geesink, HH

Citation: Pm. Edelbroek et al., Change in oxcarbazepine (Trileptal (R)) formulation is associated with more side effects and higher blood concentrations, J NE NE PSY, 71(5), 2001, pp. 708-709

Authors: Hardus, P Verduin, WM Engelsman, M Edelbroek, PM Segers, JP Berendschot, TTJM Stilma, JS

Citation: P. Hardus et al., Visual field loss associated with vigabatrin: Quantification and relation to dosage, EPILEPSIA, 42(2), 2001, pp. 262-267

Authors: Della Paschoa, OE Hoogerkamp, A Edelbroek, PM Voskuyl, RA Danhof, M

Citation: Oe. Della Paschoa et al., Pharmacokinetic-pharmacodynamic correlation of lamotrigine, flunarizine, loreclezole, CGP40116 and CGP39551 in the cortical stimulation model, EPILEPSY R, 40(1), 2000, pp. 41-52

Authors: Cleton, A de Greef, HJMM Edelbroek, PM Voskuyl, RA Danhof, M

Citation: A. Cleton et al., Application of a combined "effect compartment/indirect response model" to the central nervous system effects of tiagabine in the rat, J PHAR BIOP, 27(3), 1999, pp. 301-323

Authors: Cleton, A de Greef, HJMM Edelbroek, PM Voskuyl, RA Danhof, M

Citation: A. Cleton et al., Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4,4-di-(3-methylthien-2-yl)but-3-enyl) nipecoticacid in the rat, BR J PHARM, 128(8), 1999, pp. 1651-1658